Anyone not following this stock closely and/or who has not bought in is making a huge mistake. They are going to change the way cancer is treated as well as provide a reversal of types 1 & 2 diabetes, all by 2017.

PistolPete an confirm that as well. human clinical trials/labs are right around the corner for pancreatic cancer and diabetes is planned for later in 2017.

Pre-IND meetings have been set and on conclusion of that and IND approval it is likely off to the races for PMCB.